TIDMAGY

RNS Number : 0973U

Allergy Therapeutics PLC

27 July 2015

27 July 2015

Allergy Therapeutics plc

Director Share Dealings

On 24 July 2015, the Board of Allergy Therapeutics plc ("Allergy Therapeutics" or "the Company") was informed that on 24 July 2015, Manuel Llobet, Chief Executive Officer, purchased 50,000 ordinary shares of 0.10p ("Ordinary Shares") at a price of 24.45p per share. Mr Llobet's beneficial holding now stands at 3,175,000 Ordinary Shares, which represents 0.58% of the issued share capital of the Company to which voting rights are attached.

- Ends -

For further information:

 
                                                     +44 (0) 1903 845 
 Allergy Therapeutics                                 820 
 Ian Postlethwaite, Finance Director 
 
                                                     +44 (0) 20 7886 
 Panmure Gordon                                       2500 
 Freddy Crossley / Peter Steel / Duncan Monteith, 
  Corporate Finance 
 Tom Salvesen, Corporate Broking 
 
                                                     +44 (0) 20 3727 
 FTI Consulting                                       1000 
 Simon Conway / Victoria Foster Mitchell

Note to editors:

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSSEFEEMFISESW

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Allergy Therapeutics Charts.